-
1
-
-
0035857351
-
Osteoporosis prevention, diagnosis, and therapy
-
JAMA
-
JAMA Osteoporosis prevention, diagnosis, and therapy JAMA 2001 785 795
-
(2001)
JAMA
, pp. 785-795
-
-
-
2
-
-
0037113931
-
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function
-
A.P. Armstrong, M.E. Tometsko, M. Glaccum, C.L. Sutherland, D. Cosman, and W.C. Dougall A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function J. Biol. Chem. 277 2002 44347 44356
-
(2002)
J. Biol. Chem.
, vol.277
, pp. 44347-44356
-
-
Armstrong, A.P.1
Tometsko, M.E.2
Glaccum, M.3
Sutherland, C.L.4
Cosman, D.5
Dougall, W.C.6
-
4
-
-
0032746314
-
Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors
-
B.G. Darnay, and B.B. Aggarwal Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors Ann. Rheum. Dis. 58 1999 I2 I13
-
(1999)
Ann. Rheum. Dis.
, vol.58
-
-
Darnay, B.G.1
Aggarwal, B.B.2
-
5
-
-
84934443656
-
TRAFs in RANK signaling
-
B.G. Darnay, A. Besse, A.T. Poblenz, B. Lamothe, and J.J. Jacoby TRAFs in RANK signaling Adv. Exp. Med. Biol. 597 2007 152 159
-
(2007)
Adv. Exp. Med. Biol.
, vol.597
, pp. 152-159
-
-
Darnay, B.G.1
Besse, A.2
Poblenz, A.T.3
Lamothe, B.4
Jacoby, J.J.5
-
6
-
-
0030061068
-
Enhanced tumour specificity of an anti-carcinoembryonic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification
-
C. Delgado, R.B. Pedley, A. Herraez, R. Boden, J.A. Boden, P.A. Keep, K.A. Chester, D. Fisher, R.H. Begent, and G.E. Francis Enhanced tumour specificity of an anti-carcinoembryonic antigen Fab' fragment by poly(ethylene glycol) (PEG) modification Br. J. Cancer 73 1996 175 182
-
(1996)
Br. J. Cancer
, vol.73
, pp. 175-182
-
-
Delgado, C.1
Pedley, R.B.2
Herraez, A.3
Boden, R.4
Boden, J.A.5
Keep, P.A.6
Chester, K.A.7
Fisher, D.8
Begent, R.H.9
Francis, G.E.10
-
7
-
-
0029993066
-
Altered biodistribution of an antibody-enzyme conjugate modified with polyethylene glycol
-
E.A. Eno-Amooquaye, F. Searle, J.A. Boden, S.K. Sharma, and P.J. Burke Altered biodistribution of an antibody-enzyme conjugate modified with polyethylene glycol Br. J. Cancer 73 1996 1323 1327
-
(1996)
Br. J. Cancer
, vol.73
, pp. 1323-1327
-
-
Eno-Amooquaye, E.A.1
Searle, F.2
Boden, J.A.3
Sharma, S.K.4
Burke, P.J.5
-
8
-
-
0034691645
-
Biodistribution of fluorescinated dextran using novel nanoparticles evading reticuloendothelial system
-
U. Gaur, S.K. Sahoo, T.K. De, P.C. Ghosh, A. Maitra, and P.K. Ghosh Biodistribution of fluorescinated dextran using novel nanoparticles evading reticuloendothelial system Int. J. Pharm. 202 2000 1 10
-
(2000)
Int. J. Pharm.
, vol.202
, pp. 1-10
-
-
Gaur, U.1
Sahoo, S.K.2
De, T.K.3
Ghosh, P.C.4
Maitra, A.5
Ghosh, P.K.6
-
9
-
-
0029798819
-
Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta
-
D.E. Hughes, A. Dai, J.C. Tiffee, H.H. Li, G.R. Mundy, and B.F. Boyce Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta Nat. Med. 2 1996 1132 1136
-
(1996)
Nat. Med.
, vol.2
, pp. 1132-1136
-
-
Hughes, D.E.1
Dai, A.2
Tiffee, J.C.3
Li, H.H.4
Mundy, G.R.5
Boyce, B.F.6
-
10
-
-
0026777433
-
Increased osteoclast development after estrogen loss: Mediation by interleukin-6
-
R.L. Jilka, G. Hangoc, G. Girasole, G. Passeri, D.C. Williams, J.S. Abrams, B. Boyce, H. Broxmeyer, and S.C. Manolagas Increased osteoclast development after estrogen loss: mediation by interleukin-6 Science 257 1992 88 91
-
(1992)
Science
, vol.257
, pp. 88-91
-
-
Jilka, R.L.1
Hangoc, G.2
Girasole, G.3
Passeri, G.4
Williams, D.C.5
Abrams, J.S.6
Boyce, B.7
Broxmeyer, H.8
Manolagas, S.C.9
-
11
-
-
0001365675
-
Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model
-
N.V. Katre, M.J. Knauf, and W.J. Laird Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model Proc. Natl. Acad. Sci. U.S.A. 84 1987 1487 1491
-
(1987)
Proc. Natl. Acad. Sci. U.S.A.
, vol.84
, pp. 1487-1491
-
-
Katre, N.V.1
Knauf, M.J.2
Laird, W.J.3
-
12
-
-
0035206443
-
Minireview: The OPG/RANKL/RANK system
-
S. Khosla Minireview: the OPG/RANKL/RANK system Endocrinology 142 2001 5050 5055
-
(2001)
Endocrinology
, vol.142
, pp. 5050-5055
-
-
Khosla, S.1
-
13
-
-
0026536995
-
Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis
-
M.M. Kurfurst Detection and molecular weight determination of polyethylene glycol-modified hirudin by staining after sodium dodecyl sulfate-polyacrylamide gel electrophoresis Anal. Biochem. 200 1992 244 248
-
(1992)
Anal. Biochem.
, vol.200
, pp. 244-248
-
-
Kurfurst, M.M.1
-
15
-
-
0033561039
-
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
-
M.A. Lomaga, W.C. Yeh, I. Sarosi, G.S. Duncan, C. Furlonger, A. Ho, S. Morony, C. Capparelli, G. Van, S. Kaufman, A. van der Heiden, A. Itie, A. Wakeham, W. Khoo, T. Sasaki, Z. Cao, J.M. Penninger, C.J. Paige, D.L. Lacey, C.R. Dunstan, W.J. Boyle, D.V. Goeddel, and T.W. Mak TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling Genes Dev. 13 1999 1015 1024
-
(1999)
Genes Dev.
, vol.13
, pp. 1015-1024
-
-
Lomaga, M.A.1
Yeh, W.C.2
Sarosi, I.3
Duncan, G.S.4
Furlonger, C.5
Ho, A.6
Morony, S.7
Capparelli, C.8
Van, G.9
Kaufman, S.10
Van Der Heiden, A.11
Itie, A.12
Wakeham, A.13
Khoo, W.14
Sasaki, T.15
Cao, Z.16
Penninger, J.M.17
Paige, C.J.18
Lacey, D.L.19
Dunstan, C.R.20
Boyle, W.J.21
Goeddel, D.V.22
Mak, T.W.23
more..
-
16
-
-
0026926609
-
Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo
-
H. Maeda, L.W. Seymour, and Y. Miyamoto Conjugates of anticancer agents and polymers: advantages of macromolecular therapeutics in vivo Bioconjug. Chem. 3 1992 351 362
-
(1992)
Bioconjug. Chem.
, vol.3
, pp. 351-362
-
-
Maeda, H.1
Seymour, L.W.2
Miyamoto, Y.3
-
17
-
-
34548413629
-
Role of RANKL inhibition in osteoporosis
-
M. McClung Role of RANKL inhibition in osteoporosis Arthritis Res. Ther. 9 2007 S3
-
(2007)
Arthritis Res. Ther.
, vol.9
, pp. 3
-
-
McClung, M.1
-
18
-
-
33748918574
-
Nanomedicine: Clinical applications of polyethylene glycol conjugated proteins and drugs
-
S. Parveen, and S.K. Sahoo Nanomedicine: clinical applications of polyethylene glycol conjugated proteins and drugs Clin. Pharmacokinet. 45 2006 965 988
-
(2006)
Clin. Pharmacokinet.
, vol.45
, pp. 965-988
-
-
Parveen, S.1
Sahoo, S.K.2
-
19
-
-
34250200793
-
Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides
-
A.T. Poblenz, J.J. Jacoby, S. Singh, and B.G. Darnay Inhibition of RANKL-mediated osteoclast differentiation by selective TRAF6 decoy peptides Biochem. Biophys. Res. Commun. 359 2007 510 515
-
(2007)
Biochem. Biophys. Res. Commun.
, vol.359
, pp. 510-515
-
-
Poblenz, A.T.1
Jacoby, J.J.2
Singh, S.3
Darnay, B.G.4
-
20
-
-
33751218547
-
Therapeutic peptides: Technological advances driving peptides into development
-
A.K. Sato, M. Viswanathan, R.B. Kent, and C.R. Wood Therapeutic peptides: technological advances driving peptides into development Curr. Opin. Biotechnol. 17 2006 638 642
-
(2006)
Curr. Opin. Biotechnol.
, vol.17
, pp. 638-642
-
-
Sato, A.K.1
Viswanathan, M.2
Kent, R.B.3
Wood, C.R.4
-
21
-
-
0031005576
-
Osteoprotegerin: A novel secreted protein involved in the regulation of bone density
-
W.S. Simonet, D.L. Lacey, C.R. Dunstan, M. Kelley, M.S. Chang, R. Luthy, H.Q. Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, A. Colombero, H.L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-Gegg, T.M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. Tarpley, P. Derby, R. Lee, and W.J. Boyle Osteoprotegerin: a novel secreted protein involved in the regulation of bone density Cell 89 1997 309 319
-
(1997)
Cell
, vol.89
, pp. 309-319
-
-
Simonet, W.S.1
Lacey, D.L.2
Dunstan, C.R.3
Kelley, M.4
Chang, M.S.5
Luthy, R.6
Nguyen, H.Q.7
Wooden, S.8
Bennett, L.9
Boone, T.10
Shimamoto, G.11
Derose, M.12
Elliott, R.13
Colombero, A.14
Tan, H.L.15
Trail, G.16
Sullivan, J.17
Davy, E.18
Bucay, N.19
Renshaw-Gegg, L.20
Hughes, T.M.21
Hill, D.22
Pattison, W.23
Campbell, P.24
Sander, S.25
Van, G.26
Tarpley, J.27
Derby, P.28
Lee, R.29
Boyle, W.J.30
more..
-
22
-
-
35148889105
-
Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells
-
M. Terauchi, H. Kajiyama, K. Shibata, K. Ino, A. Nawa, S. Mizutani, and F. Kikkawa Inhibition of APN/CD13 leads to suppressed progressive potential in ovarian carcinoma cells BMC Cancer 7 2007 140
-
(2007)
BMC Cancer
, vol.7
, pp. 140
-
-
Terauchi, M.1
Kajiyama, H.2
Shibata, K.3
Ino, K.4
Nawa, A.5
Mizutani, S.6
Kikkawa, F.7
-
24
-
-
0035284411
-
Peptide and protein PEGylation: A review of problems and solutions
-
F.M. Veronese Peptide and protein PEGylation: a review of problems and solutions Biomaterials 22 2001 405 417
-
(2001)
Biomaterials
, vol.22
, pp. 405-417
-
-
Veronese, F.M.1
-
25
-
-
0032870935
-
Bioconjugation in pharmaceutical chemistry
-
F.M. Veronese, and M. Morpurgo Bioconjugation in pharmaceutical chemistry Farmaco 54 1999 497 516
-
(1999)
Farmaco
, vol.54
, pp. 497-516
-
-
Veronese, F.M.1
Morpurgo, M.2
-
26
-
-
26944452043
-
PEGylation, successful approach to drug delivery
-
F.M. Veronese, and G. Pasut PEGylation, successful approach to drug delivery Drug Discov. Today 10 2005 1451 1458
-
(2005)
Drug Discov. Today
, vol.10
, pp. 1451-1458
-
-
Veronese, F.M.1
Pasut, G.2
-
28
-
-
0030802506
-
The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage
-
R.S. Weinstein, R.L. Jilka, A.M. Parfitt, and S.C. Manolagas The effects of androgen deficiency on murine bone remodeling and bone mineral density are mediated via cells of the osteoblastic lineage Endocrinology 138 1997 4013 4021
-
(1997)
Endocrinology
, vol.138
, pp. 4013-4021
-
-
Weinstein, R.S.1
Jilka, R.L.2
Parfitt, A.M.3
Manolagas, S.C.4
-
29
-
-
33745107170
-
Strategies to improve plasma half life time of peptide and protein drugs
-
M. Werle, and A. Bernkop-Schnurch Strategies to improve plasma half life time of peptide and protein drugs Amino Acids 30 2006 351 367
-
(2006)
Amino Acids
, vol.30
, pp. 351-367
-
-
Werle, M.1
Bernkop-Schnurch, A.2
-
30
-
-
18444390259
-
Distinct molecular mechanism for initiating TRAF6 signalling
-
H. Ye, J.R. Arron, B. Lamothe, M. Cirilli, T. Kobayashi, N.K. Shevde, D. Segal, O.K. Dzivenu, M. Vologodskaia, M. Yim, K. Du, S. Singh, J.W. Pike, B.G. Darnay, Y. Choi, and H. Wu Distinct molecular mechanism for initiating TRAF6 signalling Nature 418 2002 443 447
-
(2002)
Nature
, vol.418
, pp. 443-447
-
-
Ye, H.1
Arron, J.R.2
Lamothe, B.3
Cirilli, M.4
Kobayashi, T.5
Shevde, N.K.6
Segal, D.7
Dzivenu, O.K.8
Vologodskaia, M.9
Yim, M.10
Du, K.11
Singh, S.12
Pike, J.W.13
Darnay, B.G.14
Choi, Y.15
Wu, H.16
|